Advertisement

Topics

Companies Related to "Targeted Oncology" [Most Relevant Company Matches] [Advanced Search Results] RSS

08:49 EST 17th February 2019 | BioPortfolio

Here are the most relevant search results for "Targeted Oncology" found in our extensive corporate database of over 50,000 company records.

Showing "Targeted Oncology" Companies 1–25 of 1,400+

Relevant

Loxo Oncology, Inc.

Loxo Oncology was incorporated in Delaware in May 2013 and was founded by Josh Bilenker, M.D., a partner at Aisling Capital. Loxo Oncology is committed to bringing targeted cancer therapies rapidly into the clinic that have an opportunity for outsized clinical effects in genetically defined patient populations. Loxo Oncology derives its company name from ...


TRACON Pharmaceuticals, Inc

Established in 2005 in New York as Lexington Pharmaceuticals, TRACON remains a privately held company. In April 2005, the company named Bert Liang as President and Chief Executive Officer and moved to San Diego, California. The company’s name was changed to TRACON due to the emphasis on targeted therapy for oncologic disease (TaRgeted Approach and Control in Oncology). Dr. Liang now leads a dist...

Sentinel Oncology Limited

Sentinel Oncology was founded in 2005 with the vision of developing an innovative strategy for cancer treatment, ‘Targeted Synergy’ in which a single drug can be engineered to deliver two distinct activities to the unique microenvironment of a solid tumour. In 2007, Sentinel Oncology received the much sought after Wellcome Trust Seeding Drug Discovery award for the development of Tar...


Affibody

Affibody has developed a unique pipeline of affinity ligands in oncology, covering the entire value chain from research reagents to molecular imaging agents and targeted therapeutics. The company has obtained outstanding clinical molecular imaging results and promising targeted therapeutics pre-clinical results. Affibody expects to launch one molecular imaging agent per year from 2007 and to file ...

Strategia Holdings, LLC

Strategia Holdings, LLC, is based in the U.S. and oversees three biotech companies; Spirita Oncology, LLC, Mirata BioPharma, LLC, and Strategia Pharmaceuticals, LLC. Spirita focuses on oncology drug development in the US with E6201, a MEK1 inhibitor, as their flagship candidate focused on melanoma brain metastases. Mirata is a pre-clinical stage immuno-onc...

BeiGene Ltd.

BeiGene is an innovative, clinical-stage Chinese oncology R&D company focused on discovering, developing and commercializing targeted and immune-oncology therapeutics through a novel translational research platform that leverages our strong internal oncology biology expertise with unique access to large number of patient-derived tumor biopsies. With a team...

Somanta

Our mission is to be among the leading biotechnology companies, using expertise to develop, manufacture and commercialize cancer therapeutics that address significant unmet medical needs in oncology. We are committed to high standards of integrity and to contribute to the best interests of patients, doctors, our employees, and to seeking significant returns to our stockholders, based on the contin...

Maxinovel Pharmaceuticals, Inc.

Maxinovel Pharmaceuticals, Inc. is a biotech company focusing on the discovery and development of Immuno-oncology therapy and targeted therapy. It will use its orally active Immuno-oncology product platform to bring effective combo product of multi-components in a single oral pill to the patients worldwide. For more info: www.maxinovel.com

Gibson Oncology, LLC

Gibson is a private oncology drug development company dedicated to bringing its novel, cost-effective, and very well-tolerated Indeno anti-cancer treatments to market. Gibson intends to develop these novel anti-cancer drugs in advanced-stage cancer patients as single agent and in combination treatments with both immunotherapy and targeted therapies.

BeiGene (Beijing), Co., Ltd.

BeiGene is an innovative Chinese oncology R&D company focusing on discovering, developing and commercializing targeted and immune-oncology therapeutics. With a team of 150 scientists and staff, its pipeline is comprised of novel oral small molecules and monoclonal antibodies for cancer. BeiGene Ltd. is a Cayman Islands exempted company that is an investor ...

AVEO Oncology

AVEO Oncology (NASDAQ:AVEO) is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives. AVEO’s proprietary Human Response Platform™ provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer ...

TP Therapeutics Inc.

TP Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care. Founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer’s oncology drugs crizotinib and lorlatinib, the company is developing a pipeline of novel drugs that aim to tackle treatment resistance and give new hope to patients who have ...

Access Pharmaceuticals

Access Pharmaceuticals is an emerging biotechnology company focused on the development and commercialization of products using the companies targeted delivery systems to improve clinical outcomes for patients. Together with our subsidiaries we have proprietary patents or rights to a number of drug delivery platforms,Synthetic polymer targeted delivery,Vitamin mediated targeted delivery, Vitamin me...

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion for improving the lives of cancer patients. Takeda Oncology was formerly known as Millennium: The Takeda Oncology Company. Additional information about Takeda Oncology is availabl...

Epeius Biotechnologies Corp.

Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of its leading oncology products and its tumor-targeted delivery systems. Rexin-G is currently approved for the treatment of all chemotherapy-resistant solid tumors by the Philippine FDA. To learn more about our lead products a...

IMPATH

IMPATH is in the business of improving outcomes for cancer patients. With a database of over 870,000 patient profiles, IMPATH uses sophisticated technologies to provide patient-specific diagnostic, prognostic and treatment information to more than 8,300 physicians specializing in the treatment of cancer patients, in over 2,000 hospitals and over 570 oncology practices. Utilizing its comprehensive ...

IMPATH-BCP

IMPATH is in the business of improving outcomes for cancer patients. With a database of over 870,000 patient profiles, IMPATH uses sophisticated technologies to provide patient-specific diagnostic, prognostic and treatment information to more than 8,300 physicians specializing in the treatment of cancer patients, in over 2,000 hospitals and over 570 oncology practices. Utilizing its comprehensive ...

VioQuest Pharmaceuticals

VioQuest Pharmaceuticals, Inc. acquires, develops, and commercializes targeted late preclinical and early clinical stage therapies with unique mechanisms of action for oncology, viral and autoimmune disorders. A pioneer in personalized therapeutics, VioQuest has two targeted therapeutics in clinical trials: VQD-001, an inhibitor of specific protein tyrosine phosphatases, has shown compelling precl...

Xcovery

Xcovery is a clinical-stage company focused on the development of next-generation targeted therapeutics for cancer. Founded by Sheridan G. Snyder and Chris Liang, PhD, Xcovery’s vision is to successfully develop innovative oncology therapies to optimize patient outcomes. Through innovative drug design, Xcovery has developed a comprehensive pipeline of...

Turning Point Therapeutics, Inc.

Turning Point Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care. Founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer’s oncology drugs crizotinib and lorlatinib, the company is developing a pipeline of novel drugs that aim to tackle treatment resistance and give new hope to patie...

OncLive

OncLive is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. The mission of OncLive and its family of publications is to provide oncology professionals with the resources and information they need to provide the best care for their...

Targeted Genetics Corporation

Targeted Genetics Corporation is a biotechnology company committed to the development and commercialization of innovative therapies for the prevention and treatment of diseases with significant unmet medical need. To learn more about Targeted Genetics, visit Targeted Genetics' website at www.targetedgenetics.com.

Targos Molecular Pathology GmbH

"Targos focuses on the application, discovery and development of predictive biomarkers in oncology. Targeted therapies in oncology usually require biomarker guidance in development and clinical application for ethical, economic and regulatory reasons. Targos combines molecular pathology expertise with highly standardized analytics and applies strict project and quality management to provide the in...

MabSpace Biosciences Co., Limited

MabSpace Biosciences Co., Ltd. is a private, venture-backed biotechnology company specialized in discovering and developing innovative antibody therapeutics using its proprietary immune tolerance breaking technology platform. MabSpace has built up a pipeline in immune-oncology, ophthalmology as well as nephrology. The immune-oncology (IO) pipeline is spear...

Pacific Shores Medical Group

We are a specialized hematology and oncology practice providing state-of-the-art treatments for adult patients with any type of cancer or blood disorder. We have been in operation for 20 years, and we care for thousands of patients every year. Our practice includes 12 medical oncologists, 5 offices, and over 100 highly trained and experienced staff members. We offer the best current treatment opti...


More From BioPortfolio on "Targeted Oncology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks